Creative Medical Technology HOLDINGS, Inc. (CELZ) intrinsic value & 10-year financials
Creative Medical Technology HOLDINGS, Inc. (CELZ) has a Graham intrinsic value of $68.53 per share. At $0.74 on Oct 17, 2026, the stock trades 99% below that value. Over the last 10 fiscal years revenue grew 2.8% a year to $6.0K, with an average return on invested capital of 34.9%.
- Graham intrinsic value
- $68.53
- Share price (Oct 17, 2026)
- $0.74
- Price vs Graham value
- 99% below
- Market cap
- $1.8M
- Revenue (FY2025)
- $6.0K
- Revenue growth (10-yr CAGR)
- 2.8%
- ROIC (10-yr avg)
- 34.9%
- Free cash flow (FY2025)
- —
CELZ 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $6.0K | -$6.0M | -$2.52 | — | -102380.2% | — |
| FY2024 | $11.0K | -$5.5M | -$3.71 | — | -52216.9% | — |
| FY2023 | $9.0K | -$5.3M | -$3.76 | — | -62445.9% | — |
| FY2022 | $88.6K | -$10.1M | -$0.93 | — | -11562.5% | — |
| FY2021 | $87.8K | $19.2M | $5.61 | — | -3562.2% | — |
| FY2020 | $164.5K | -$36.3M | -$62.69 | — | -677.7% | 2.8% |
| FY2019 | $165.5K | -$8.5M | — | — | -682.9% | — |
| FY2018 | $124.4K | -$13.7M | — | — | -895.7% | — |
| FY2017 | $4.8K | -$2.7M | — | — | -24537.6% | 67.0% |
| FY2016 | $0 | -$766.1K | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. has earned high returns on invested capital, averaging 34.9% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. is modeled at 2.8% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $68.53 per share.